Robin Fastenau

Stock Building Supply Holdings, Inc. is a diversified lumber and building materials distributor and solutions provider that sell to new construction and repair and remodel contractors. The company primary products are lumber & lumber sheet goods, millwork, doors, flooring, windows, structural components, such as engineered wood products, trusses, wall panels and other exterior products. It provides solution-based services to its customers, including design, product specification and installation management services. The company serves a broad customer base, including large-scale production homebuilders, custom homebuilders and repair and remodeling contractor. It was formerly known as Saturn Acquisition Holdings LLC and changed its name to Stock Building Supply Holdings, Inc. in May 2013. The company's business roots back to 1922. Stock Building Supply Holdings was founded on April 16, 2009 and is headquartered in Raleigh, NC.

BMC East LLC supplies building materials to home builders and contractors. It offers residential, light commercial, home repair and remodel construction markets. The company was founded on May 30, 1922 and is headquartered in Raleigh, NC.

Metabolon, Inc. operates as a health technology company. It offers precision medicine, clinical diagnostic, and metabolomics services. The firm serves to the pharmaceutical, biotechnology, consumer product industries. The company was founded in 2000 and is headquartered in Morrisville, NC.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.

Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC.